New Risk • Apr 29
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 10% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (10% average weekly change). Earnings have declined by 25% per year over the past 5 years. Minor Risk Large one-off items impacting financial results. Reported Earnings • Apr 25
First quarter 2026 earnings released: EPS: CN¥0.08 (vs CN¥0.09 in 1Q 2025) First quarter 2026 results: EPS: CN¥0.08 (down from CN¥0.09 in 1Q 2025). Revenue: CN¥472.9m (down 11% from 1Q 2025). Net income: CN¥28.6m (down 2.3% from 1Q 2025). Profit margin: 6.1% (up from 5.5% in 1Q 2025). Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has only increased by 22% per year, which means it is significantly lagging earnings growth. Duyuru • Apr 25
Guizhou RedStar Developing Co.,Ltd., Annual General Meeting, May 18, 2026 Guizhou RedStar Developing Co.,Ltd., Annual General Meeting, May 18, 2026, at 14:30 China Standard Time. Location: The Company's Meeting Room, Anshun, Guizhou China Duyuru • Mar 30
Guizhou RedStar Developing Co.,Ltd. to Report Q1, 2026 Results on Apr 25, 2026 Guizhou RedStar Developing Co.,Ltd. announced that they will report Q1, 2026 results on Apr 25, 2026 Valuation Update With 7 Day Price Move • Mar 16
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to CN¥26.81, the stock trades at a trailing P/E ratio of 65.8x. Average trailing P/E is 50x in the Chemicals industry in China. Total returns to shareholders of 80% over the past three years. Valuation Update With 7 Day Price Move • Mar 02
Investor sentiment improves as stock rises 26% After last week's 26% share price gain to CN¥23.55, the stock trades at a trailing P/E ratio of 57.8x. Average trailing P/E is 52x in the Chemicals industry in China. Total returns to shareholders of 45% over the past three years. Duyuru • Dec 26
Guizhou RedStar Developing Co.,Ltd. to Report Fiscal Year 2025 Results on Apr 25, 2026 Guizhou RedStar Developing Co.,Ltd. announced that they will report fiscal year 2025 results on Apr 25, 2026 New Risk • Dec 25
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 13% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (7.0% average weekly change). Valuation Update With 7 Day Price Move • Dec 22
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to CN¥18.15, the stock trades at a trailing P/E ratio of 44.6x. Average trailing P/E is 42x in the Chemicals industry in China. Total returns to shareholders of 16% over the past three years. Valuation Update With 7 Day Price Move • Nov 24
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to CN¥15.93, the stock trades at a trailing P/E ratio of 39.1x. Average trailing P/E is 41x in the Chemicals industry in China. Total loss to shareholders of 4.5% over the past three years. Reported Earnings • Oct 26
Third quarter 2025 earnings released: EPS: CN¥0.081 (vs CN¥0.099 in 3Q 2024) Third quarter 2025 results: EPS: CN¥0.081 (down from CN¥0.099 in 3Q 2024). Revenue: CN¥528.5m (down 7.1% from 3Q 2024). Net income: CN¥28.9m (down 15% from 3Q 2024). Profit margin: 5.5% (down from 6.0% in 3Q 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings. Duyuru • Sep 30
Guizhou RedStar Developing Co.,Ltd. to Report Q3, 2025 Results on Oct 25, 2025 Guizhou RedStar Developing Co.,Ltd. announced that they will report Q3, 2025 results on Oct 25, 2025 Reported Earnings • Aug 25
Second quarter 2025 earnings released: EPS: CN¥0.14 (vs CN¥0.048 in 2Q 2024) Second quarter 2025 results: EPS: CN¥0.14 (up from CN¥0.048 in 2Q 2024). Revenue: CN¥548.2m (flat on 2Q 2024). Net income: CN¥49.1m (up 185% from 2Q 2024). Profit margin: 9.0% (up from 3.1% in 2Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 58 percentage points per year, which is a significant difference in performance. Duyuru • Jun 30
Guizhou RedStar Developing Co.,Ltd. to Report First Half, 2025 Results on Aug 23, 2025 Guizhou RedStar Developing Co.,Ltd. announced that they will report first half, 2025 results on Aug 23, 2025 New Risk • Jun 26
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 6.0% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (8.2% average weekly change). Valuation Update With 7 Day Price Move • Jun 19
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to CN¥16.08, the stock trades at a trailing P/E ratio of 49x. Average trailing P/E is 36x in the Chemicals industry in China. Total loss to shareholders of 27% over the past three years. Declared Dividend • Jun 07
Dividend increased to CN¥0.02 Dividend of CN¥0.02 is 100% higher than last year. Ex-date: 13th June 2025 Payment date: 13th June 2025 Dividend yield will be 0.2%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (9% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 4.4% per year over the past 10 years. However, payments have been volatile during that time. Earnings per share has grown by 15% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Reported Earnings • Apr 28
First quarter 2025 earnings released: EPS: CN¥0.09 (vs CN¥0.02 in 1Q 2024) First quarter 2025 results: EPS: CN¥0.09 (up from CN¥0.02 in 1Q 2024). Revenue: CN¥532.7m (up 8.1% from 1Q 2024). Net income: CN¥29.3m (up 363% from 1Q 2024). Profit margin: 5.5% (up from 1.3% in 1Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 71 percentage points per year, which is a significant difference in performance. New Risk • Apr 27
New major risk - Revenue and earnings growth Earnings have declined by 4.6% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 4.6% per year over the past 5 years. Minor Risk Large one-off items impacting financial results. Duyuru • Apr 26
Guizhou RedStar Developing Co.,Ltd., Annual General Meeting, May 23, 2025 Guizhou RedStar Developing Co.,Ltd., Annual General Meeting, May 23, 2025, at 14:30 China Standard Time. Location: 4F, No. 8, Jiyang Road, Shibei District, Qingdao, Shandong China Valuation Update With 7 Day Price Move • Apr 08
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to CN¥12.05, the stock trades at a trailing P/E ratio of 62.9x. Average trailing P/E is 33x in the Chemicals industry in China. Total loss to shareholders of 49% over the past three years. Duyuru • Mar 28
Guizhou RedStar Developing Co.,Ltd. to Report Q1, 2025 Results on Apr 26, 2025 Guizhou RedStar Developing Co.,Ltd. announced that they will report Q1, 2025 results on Apr 26, 2025 Valuation Update With 7 Day Price Move • Mar 07
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to CN¥15.26, the stock trades at a trailing P/E ratio of 79.6x. Average trailing P/E is 37x in the Chemicals industry in China. Total loss to shareholders of 26% over the past three years. New Risk • Jan 29
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.8% average weekly change). Large one-off items impacting financial results. Valuation Update With 7 Day Price Move • Jan 16
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to CN¥14.47, the stock trades at a trailing P/E ratio of 75.5x. Average trailing P/E is 34x in the Chemicals industry in China. Total loss to shareholders of 3.5% over the past three years. Duyuru • Dec 27
Guizhou RedStar Developing Co.,Ltd. to Report Fiscal Year 2024 Results on Apr 26, 2025 Guizhou RedStar Developing Co.,Ltd. announced that they will report fiscal year 2024 results on Apr 26, 2025 Valuation Update With 7 Day Price Move • Nov 22
Investor sentiment improves as stock rises 27% After last week's 27% share price gain to CN¥14.52, the stock trades at a trailing P/E ratio of 75.8x. Average trailing P/E is 36x in the Chemicals industry in China. Total loss to shareholders of 9.7% over the past three years. Reported Earnings • Oct 22
Third quarter 2024 earnings released: EPS: CN¥0.099 (vs CN¥0.11 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.099. Revenue: CN¥569.1m (up 3.7% from 3Q 2023). Net income: CN¥33.9m (up 133% from 3Q 2023). Profit margin: 6.0% (up from 2.7% in 3Q 2023). Duyuru • Sep 30
Guizhou RedStar Developing Co.,Ltd. to Report Q3, 2024 Results on Oct 22, 2024 Guizhou RedStar Developing Co.,Ltd. announced that they will report Q3, 2024 results on Oct 22, 2024 Upcoming Dividend • Sep 23
Upcoming dividend of CN¥0.01 per share Eligible shareholders must have bought the stock before 30 September 2024. Payment date: 30 September 2024. Payout ratio is a comfortable 11% and this is well supported by cash flows. Trailing yield: 0.2%. Lower than top quartile of Chinese dividend payers (2.8%). Lower than average of industry peers (2.2%). New Risk • Sep 17
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Shareholders have been diluted in the past year (16% increase in shares outstanding). Buy Or Sell Opportunity • Jul 26
Now 23% overvalued Over the last 90 days, the stock has fallen 13% to CN¥9.60. The fair value is estimated to be CN¥7.82, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 6.8% over the last 3 years. Earnings per share has declined by 39%. Duyuru • Jun 28
Guizhou RedStar Developing Co.,Ltd. to Report First Half, 2024 Results on Aug 28, 2024 Guizhou RedStar Developing Co.,Ltd. announced that they will report first half, 2024 results on Aug 28, 2024 Duyuru • Apr 27
Guizhou RedStar Developing Co.,Ltd., Annual General Meeting, May 22, 2024 Guizhou RedStar Developing Co.,Ltd., Annual General Meeting, May 22, 2024, at 14:30 China Standard Time. Location: 4F, No. 8, Jiyang Road, Shibei District, Qingdao, Shandong China Reported Earnings • Apr 26
First quarter 2024 earnings released: EPS: CN¥0.02 (vs CN¥0.02 loss in 1Q 2023) First quarter 2024 results: EPS: CN¥0.02 (up from CN¥0.02 loss in 1Q 2023). Revenue: CN¥492.6m (up 2.6% from 1Q 2023). Net income: CN¥6.34m (up CN¥12.8m from 1Q 2023). Profit margin: 1.3% (up from net loss in 1Q 2023). Over the last 3 years on average, earnings per share has fallen by 39% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings. Duyuru • Mar 30
Guizhou RedStar Developing Co.,Ltd. to Report Q1, 2024 Results on Apr 26, 2024 Guizhou RedStar Developing Co.,Ltd. announced that they will report Q1, 2024 results on Apr 26, 2024 Duyuru • Dec 29
Guizhou RedStar Developing Co.,Ltd. to Report Fiscal Year 2023 Results on Apr 26, 2024 Guizhou RedStar Developing Co.,Ltd. announced that they will report fiscal year 2023 results on Apr 26, 2024 New Risk • Dec 03
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 16% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite being loss-making. Shareholders have been diluted in the past year (16% increase in shares outstanding). Reported Earnings • Nov 01
Third quarter 2023 earnings released: EPS: CN¥0.11 (vs CN¥0.091 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.11. Revenue: CN¥548.9m (down 14% from 3Q 2022). Net income: CN¥14.6m (down 45% from 3Q 2022). Profit margin: 2.7% (down from 4.1% in 3Q 2022). The decrease in margin was driven by lower revenue. Buying Opportunity • Oct 11
Now 20% undervalued after recent price drop Over the last 90 days, the stock is down 14%. The fair value is estimated to be CN¥16.66, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 28% over the last 3 years. Earnings per share has grown by 35%. Buying Opportunity • Sep 26
Now 21% undervalued The stock has been flat over the last 90 days. The fair value is estimated to be CN¥16.70, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 28% over the last 3 years. Earnings per share has grown by 35%. New Risk • Aug 28
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 23% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by earnings (158% payout ratio). Share price has been volatile over the past 3 months (7.7% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.7% net profit margin). Reported Earnings • Aug 28
Second quarter 2023 earnings released: EPS: CN¥0.022 (vs CN¥0.38 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.022 (down from CN¥0.38 in 2Q 2022). Revenue: CN¥539.0m (down 12% from 2Q 2022). Net income: CN¥10.4m (down 91% from 2Q 2022). Profit margin: 1.9% (down from 18% in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Jul 03
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to CN¥15.87, the stock trades at a trailing P/E ratio of 39.6x. Average trailing P/E is 29x in the Chemicals industry in China. Total returns to shareholders of 118% over the past three years. New Risk • Jun 25
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (6.8% average weekly change). Profit margins are more than 30% lower than last year (4.5% net profit margin). Valuation Update With 7 Day Price Move • Jun 08
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to CN¥14.64, the stock trades at a trailing P/E ratio of 36.5x. Average trailing P/E is 28x in the Chemicals industry in China. Total returns to shareholders of 114% over the past three years. Reported Earnings • Apr 22
Full year 2022 earnings released: EPS: CN¥0.74 (vs CN¥0.90 in FY 2021) Full year 2022 results: EPS: CN¥0.74 (down from CN¥0.90 in FY 2021). Revenue: CN¥2.85b (up 30% from FY 2021). Net income: CN¥214.9m (down 18% from FY 2021). Profit margin: 7.5% (down from 12% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 74% per year but the company’s share price has only increased by 26% per year, which means it is significantly lagging earnings growth. Buying Opportunity • Dec 19
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 18%. The fair value is estimated to be CN¥20.30, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 78%. Buying Opportunity • Nov 18
Now 22% undervalued after recent price drop Over the last 90 days, the stock is down 29%. The fair value is estimated to be CN¥22.23, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 78%. Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Director Yongmei Zhang was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Duyuru • Nov 02
Guizhou RedStar Developing Co.,Ltd. announced that it expects to receive CNY 580 million in funding from Qingdao Redstar Chemical Group Company Ltd. and other investors Guizhou RedStar Developing Co.,Ltd. announced that it has entered into share subscription agreement not more than 87,970,980 A shares pre-plan at an issue price for an aggregate gross proceeds of not more than CNY 580,000,000 on October 31, 2022. The company shall issue shares at a price not less than 80% of the average price in the 20 trading days before the pricing reference date. The transaction will include participation from not more than 35, including Qingdao Redstar Chemical Group Company Ltd. The shares to be issued shall have a hold period of 18 months and 6 months for Qingdao Redstar Chemical Group Company Ltd and other investors respectively. The transaction has been approved at the 10th meeting of the 8th supervisory board of the company. The transaction is still subject to the approvals of the company’s shareholders, the State-owned Assets Supervision and Administration, and the China Securities Regulatory Commission. Duyuru • Oct 29
Guizhou RedStar Developing Co.,Ltd. (SHSE:600367) signed an agreement to acquire 75% stake in Qingdao Red Butterfly Precision Materials Co., Ltd. from Qingdao Redstar Chemical Group Company Ltd. for CNY 405 million. Guizhou RedStar Developing Co.,Ltd. (SHSE:600367) signed an agreement to acquire 75% stake in Qingdao Red Butterfly Precision Materials Co., Ltd. from Qingdao Redstar Chemical Group Company Ltd. for CNY 405 million on October 27, 2022. As per the terms of agreement, Guizhou RedStar Developing will pay first installment of CNY 300 million within five working days from the date of signing the agreement and second installment of CNY 106.96428 will pay within one year from signing the agreement. Reported Earnings • Oct 28
Third quarter 2022 earnings released: EPS: CN¥0.091 (vs CN¥0.24 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.091 (down from CN¥0.24 in 3Q 2021). Revenue: CN¥640.0m (up 18% from 3Q 2021). Net income: CN¥26.4m (down 62% from 3Q 2021). Profit margin: 4.1% (down from 13% in 3Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 78% per year but the company’s share price has only increased by 33% per year, which means it is significantly lagging earnings growth. Reported Earnings • Aug 12
Second quarter 2022 earnings released: EPS: CN¥0.38 (vs CN¥0.18 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.38 (up from CN¥0.18 in 2Q 2021). Revenue: CN¥610.7m (up 15% from 2Q 2021). Net income: CN¥110.6m (up 101% from 2Q 2021). Profit margin: 18% (up from 10% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 73% per year but the company’s share price has only increased by 48% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Aug 09
Investor sentiment improved over the past week After last week's 15% share price gain to CN¥26.85, the stock trades at a trailing P/E ratio of 23.6x. Average trailing P/E is 29x in the Chemicals industry in China. Total returns to shareholders of 261% over the past three years. Valuation Update With 7 Day Price Move • Jul 18
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥25.29, the stock trades at a trailing P/E ratio of 22.2x. Average trailing P/E is 28x in the Chemicals industry in China. Total returns to shareholders of 222% over the past three years. Valuation Update With 7 Day Price Move • Jun 14
Investor sentiment improved over the past week After last week's 17% share price gain to CN¥23.03, the stock trades at a trailing P/E ratio of 20.2x. Average trailing P/E is 27x in the Chemicals industry in China. Total returns to shareholders of 164% over the past three years. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. 3 independent directors (7 non-independent directors). Director Yang Wan was the last director to join the board, commencing their role in 2015. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Mar 01
Investor sentiment improved over the past week After last week's 19% share price gain to CN¥26.50, the stock trades at a trailing P/E ratio of 37.8x. Average trailing P/E is 33x in the Chemicals industry in China. Total returns to shareholders of 207% over the past three years. Valuation Update With 7 Day Price Move • Jan 25
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥18.36, the stock trades at a trailing P/E ratio of 26.2x. Average trailing P/E is 33x in the Chemicals industry in China. Total returns to shareholders of 154% over the past three years. Valuation Update With 7 Day Price Move • Dec 21
Investor sentiment deteriorated over the past week After last week's 19% share price decline to CN¥18.97, the stock trades at a trailing P/E ratio of 27.1x. Average trailing P/E is 33x in the Chemicals industry in China. Total returns to shareholders of 164% over the past three years. Valuation Update With 7 Day Price Move • Nov 30
Investor sentiment improved over the past week After last week's 20% share price gain to CN¥18.94, the stock trades at a trailing P/E ratio of 27x. Average trailing P/E is 35x in the Chemicals industry in China. Total returns to shareholders of 142% over the past three years. Reported Earnings • Oct 25
Third quarter 2021 earnings released: EPS CN¥0.24 (vs CN¥0.042 loss in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥544.5m (up 66% from 3Q 2020). Net income: CN¥68.7m (up CN¥75.9m from 3Q 2020). Profit margin: 13% (up from net loss in 3Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has increased by 35% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Sep 27
Investor sentiment deteriorated over the past week After last week's 17% share price decline to CN¥17.78, the stock trades at a trailing P/E ratio of 40.3x. Average trailing P/E is 34x in the Chemicals industry in China. Total returns to shareholders of 114% over the past three years. Valuation Update With 7 Day Price Move • Sep 10
Investor sentiment improved over the past week After last week's 38% share price gain to CN¥21.46, the stock trades at a trailing P/E ratio of 45.3x. Average trailing P/E is 34x in the Chemicals industry in China. Total returns to shareholders of 166% over the past three years. Valuation Update With 7 Day Price Move • Aug 27
Investor sentiment improved over the past week After last week's 22% share price gain to CN¥17.09, the stock trades at a trailing P/E ratio of 36.1x. Average trailing P/E is 32x in the Chemicals industry in China. Total returns to shareholders of 105% over the past three years. Reported Earnings • Aug 15
Second quarter 2021 earnings released: EPS CN¥0.18 (vs CN¥0.011 in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥529.9m (up 65% from 2Q 2020). Net income: CN¥55.1m (up CN¥51.1m from 2Q 2020). Profit margin: 10% (up from 1.3% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has increased by 24% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Aug 12
Investor sentiment improved over the past week After last week's 18% share price gain to CN¥14.86, the stock trades at a trailing P/E ratio of 54.7x. Average trailing P/E is 31x in the Chemicals industry in China. Total returns to shareholders of 74% over the past three years. Valuation Update With 7 Day Price Move • Jul 23
Investor sentiment improved over the past week After last week's 15% share price gain to CN¥11.97, the stock trades at a trailing P/E ratio of 44x. Average trailing P/E is 31x in the Chemicals industry in China. Total returns to shareholders of 32% over the past three years. Valuation Update With 7 Day Price Move • Jul 07
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥9.81, the stock trades at a trailing P/E ratio of 36.1x. Average trailing P/E is 29x in the Chemicals industry in China. Total returns to shareholders of 17% over the past three years. Valuation Update With 7 Day Price Move • May 21
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥9.20, the stock trades at a trailing P/E ratio of 33.9x. Average trailing P/E is 28x in the Chemicals industry in China. Total loss to shareholders of 8.1% over the past three years. Reported Earnings • Apr 11
Full year 2020 earnings released: EPS CN¥0.19 (vs CN¥0.26 in FY 2019) The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥1.38b (down 9.6% from FY 2019). Net income: CN¥55.1m (down 26% from FY 2019). Profit margin: 4.0% (down from 4.9% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings. Is New 90 Day High Low • Feb 25
New 90-day high: CN¥8.03 The company is up 8.0% from its price of CN¥7.45 on 27 November 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 17% over the same period. Is New 90 Day High Low • Feb 04
New 90-day low: CN¥6.40 The company is down 9.0% from its price of CN¥7.06 on 06 November 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 20% over the same period. Duyuru • Jan 31
Qingdao Port International Co., Ltd. (SEHK:6198) completed the acquisition of 31.92% stake in Qingdao Red Star Logistics Industry Co. Ltd. from Guizhou RedStar Developing Co.,Ltd. (SHSE:600367) for approximately CNY 120 million. Qingdao Port International Co., Ltd. (SEHK:6198) entered into a share transfer agreement to acquire 31.92% stake in Qingdao Red Star Logistics Industry Co. Ltd. from Guizhou RedStar Developing Co.,Ltd. (SHSE:600367) on April 9, 2020. Qingdao Port International Co., Ltd. also acquired creditor's rights. The equity transfer is for CNY 64.1 million. The consideration will be paid in tranches. Qingdao Red Star Logistics Industry Co. Ltd. reported total assets of CNY 306.4 million and net assets of CNY 30.7 million as of April 30, 2019. The transaction has been approved by the Board of Guizhou RedStar Developing Co.,Ltd.
Qingdao Port International Co., Ltd. (SEHK:6198) completed the acquisition of 31.92% stake in Qingdao Red Star Logistics Industry Co. Ltd. from Guizhou RedStar Developing Co.,Ltd. (SHSE:600367) for approximately CNY 120 million on January 29, 2021. Guizhou RedStar Developing Co.,Ltd has received a total of 90% of the equity transfer price of CNY 57.6 million and 90% of the creditor’s rights transfer price of CNY 48.3 million. The remaining 10% of the equity transfer price and creditor's rights transfer price will be paid within 10 working days from the date when Qingdao Red Star Logistics Industry Co. Ltd completes the real estate certificate procedures. Is New 90 Day High Low • Jan 13
New 90-day low: CN¥6.61 The company is down 8.0% from its price of CN¥7.22 on 15 October 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period. Is New 90 Day High Low • Dec 10
New 90-day high: CN¥7.74 The company is up 6.0% from its price of CN¥7.31 on 11 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 10.0% over the same period. Is New 90 Day High Low • Oct 31
New 90-day low: CN¥6.89 The company is down 11% from its price of CN¥7.76 on 31 July 2020. The Chinese market is down 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is flat over the same period. Reported Earnings • Oct 17
Third quarter earnings released Over the last 12 months the company has reported total profits of CN¥2.85m, down 96% from the prior year. Total revenue was CN¥1.28b over the last 12 months, down 20% from the prior year. Duyuru • Oct 15
Guizhou RedStar Developing Co.,Ltd. to Report Q3, 2020 Results on Oct 17, 2020 Guizhou RedStar Developing Co.,Ltd. announced that they will report Q3, 2020 results on Oct 17, 2020 
